Holen Sie sich die Stockscreener-App
18.47
3.85%
-0.74
Vorhandelsmarkt:
18.00
-0.47
-2.54%
Schlusskurs vom Vortag:
$19.21
Offen:
$18
24-Stunden-Volumen:
8,126
Relative Volume:
0.20
Marktkapitalisierung:
$4.03B
Einnahmen:
$8.16M
Nettoeinkommen (Verlust:
$-7.54M
KGV:
-0.514
EPS:
-35.932
Netto-Cashflow:
$-3.75M
1W Leistung:
-31.77%
1M Leistung:
-33.56%
6M Leistung:
-34.36%
1J Leistung:
-79.60%
1-Tages-Spanne:
$18.00
$18.89
1-Wochen-Bereich:
$18.00
$27.00
52-Wochen-Spanne:
$8.00
$358.00
Garden Stage Ltd Stock (GSIW) Company Profile
Firmenname
Garden Stage Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare GSIW vs MS, GS, SCHW, HOOD, CRCL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GSIW
Garden Stage Ltd
|
18.47 | 4.19B | 8.16M | -7.54M | -3.75M | -35.93 |
|
MS
Morgan Stanley
|
157.83 | 247.23B | 119.71B | 17.03B | 46.10B | 10.21 |
|
GS
Goldman Sachs Group Inc
|
807.04 | 235.85B | 126.15B | 17.18B | 23.15B | 51.30 |
|
SCHW
Charles Schwab Corp
|
93.93 | 164.06B | 27.68B | 8.85B | 13.27B | 4.6601 |
|
HOOD
Robinhood Markets Inc
|
77.35 | 67.80B | 4.51B | 1.88B | -3.42B | 2.059 |
|
CRCL
Circle Internet Group Inc
|
132.31 | 31.06B | 2.75B | -69.52M | 473.50M | -0.5429 |
Garden Stage Ltd Aktie (GSIW) Neueste Nachrichten
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - The Manila Times
Dip Buying: Can Garden Stage Limited lead its sector in growth2026 Technical Overview & Verified Technical Signals - baoquankhu1.vn
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update - Yahoo Finance
Nektar Therapeutics Q4 Earnings Call Highlights - Yahoo Finance
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results - finance.yahoo.com
BridgeBio Pharma CEO Teases Pipeline Launches, Attruby Momentum, and Pfizer Tafamidis Trial Update - Yahoo Finance
Can Garden Stage Limited lead its sector in growthMarket Movement Recap & Expert Verified Stock Movement Alerts - baoquankhu1.vn
LEIFRAS Co., Ltd. Announces Commencement of Preparations for Dual Listing on the Tokyo Stock Exchange - Yahoo Finance
Axsome Therapeutics Highlights Auvelity’s $500M+ Run, FDA Catalyst and Late-Stage Pipeline at Conference - Yahoo Finance
Disney Sells Out Oscars Ad Inventory With 76% Increase in Streaming Revenue - Yahoo Finance Singapore
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange - Yahoo Finance
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results - Yahoo Finance
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update - Yahoo Finance
Digitalage Enters Controlled Production Deployment as Live Creator Broadcasting Begins and Newsroom OS Activates in TestFlight - Yahoo Finance
Altimmune Touts Pemvidutide Progress, Targets MASH Phase 3 Start and Q3 AUD Readout at Barclays Chat - finance.yahoo.com
GSIW SEC FilingsGarden Stage Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
Garden Stage Wins Nasdaq Bid-Price Extension and Enacts 200-for-1 Share Consolidation - The Globe and Mail
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID - Yahoo Finance
Aura Biosciences Eyes Phase 3 Enrollment Milestone, Reaffirms Q4 2027 Melanoma Data Timeline - Yahoo Finance
Disney Cruise First Look: Parents Hacks, Tips & What To Expect - Sassy Mama Singapore
AnaptysBio Plans First Tracks Spin-Off as Jemperli Royalties Surge, Buybacks Possible - Yahoo Finance
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. - Yahoo Finance
Altimmune Details Pemvidutide Phase III MASH Plans, Breakthrough Status at Citizens Conference - Yahoo Finance
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Yahoo Finance
Oil prices fall after Trump says war will end 'soon' - Yahoo Finance
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Recent 1‑Year Share Slump Accurately - Yahoo Finance
Collective Metals Confirms Anomalous Uranium and High-Grade Rare Earth Element Mineralization up to 9.83% TREO* at Surface on the Rocas Project - Yahoo Finance
Immersion Cooling Market to Reach USD 4,917.0 Million by 2033 as AI Data Centers Adoption Accelerated - Yahoo Finance
Nevada Sunrise Resamples 50.2 Metres of 1.013 Grams/Tonne Gold from Historical Drill Hole at the Griffon Gold Mine Project, Nevada - Yahoo Finance
Standard Uranium Confirms Anomalous Uranium and High-Grade Rare Earth Element Mineralization up to 9.83% TREO* at Surface on the Rocas Project - Yahoo Finance
Gas Mixtures Market worth $35.04 billion by 2030Exclusive Report by MarketsandMarkets™ - Yahoo Finance
Alzheon to Present Clinical, Imaging, and Fluid Biomarker Results from Trials with Oral Valiltramiprosate/ALZ-801 at 2026 AD/PD Conference in Copenhagen, Denmark - Yahoo Finance
Kincora Consolidates, Commences Geophysics and Forms Partnership at Cowal East - Yahoo Finance
11 Medical Expenses Medicare Won’t Pay For (It's a Lot) - Yahoo Finance
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers - Yahoo Finance
Evolt Charging partners with AMPECO to support the next phase of EV Charging - Yahoo Finance
Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Benzinga
European freight truck makers brace for wave of low-cost Chinese rivals - Yahoo Finance
Alumis Teases TYK2 Catalysts at Leerink: Phase III Psoriasis Wins, NDA Plan and Lupus Readout Ahead - Yahoo Finance
AdaptHealth Calls 2025 a Transition Year, Builds for 2026 Growth Ahead of Kaiser DME Deal - Yahoo Finance
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives - Yahoo Finance
Garden Stage Limited Announces Major Share Reclassification on Nasdaq - timothysykes.com
Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology - Yahoo Finance
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures - Yahoo Finance
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma - Yahoo Finance
Is It Too Late To Consider Ralph Lauren (RL) After A 56.9% One Year Surge? - Yahoo Finance
Radiant Health Centers Announces Honorees for 40th Annual Gala Celebrating Four Decades of Compassionate Care - Yahoo Finance
Hemostemix Leadership Attending Abundance360 Summit - Yahoo Finance
Is Antero Resources (AR) Still Attractively Priced After Strong Multi‑Year Share Gains? - Yahoo Finance
Greenland’s Untested Oil Basin Could Be the Next Big Discovery - Yahoo Finance
Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
Finanzdaten der Garden Stage Ltd-Aktie (GSIW)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):